<DOC>
	<DOC>NCT02623881</DOC>
	<brief_summary>To compare the effectiveness of cervical pessary (Arabin) and vaginal progesterone for preventing premature birth in twin pregnancies after IVF</brief_summary>
	<brief_title>Cervical Pessary vs. Vaginal Progesterone for Preventing Premature Birth in IVF Twin Pregnancies</brief_title>
	<detailed_description>This is a randomized controlled trial. Women with twin pregnancies after IVF treatment, at 16-22 weeks of gestation, will be invited to participate into the study. Subjects meeting the study criteria will be randomized into two groups: (1) treated with cervical pessary (Arabin) or (2) treated with 400mg vaginal progesterone, once daily from 16-22 weeks to 36 6/7 weeks. Sample size: 520 participants</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>To be eligible for enrolment into this trial, each female subject must fulfil all of the following criteria at the start of enrolment, unless specified otherwise: Twin (mono or dichorionic) pregnancy. Cervical length (measured at 1622 weeks of gestation) &lt; 38 mm. Willing to participate in the study To be eligible for enrolment in this study each subject must not meet any of the following criteria: Cervical cerclage in place . Stillbirth or major congenital abnormalities in any of the baby Twintwin transfusion syndrome Praevia placenta Severe vaginal discharge, Premature rupture of membranes Premature labor / Premature rupture of membrane Participate in another intervention trial</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Cervical pessary</keyword>
	<keyword>Vaginal progesterone</keyword>
	<keyword>Twins</keyword>
	<keyword>Premature birth</keyword>
</DOC>